Resistance (Psychotherapeutic)

FDA Approves Iterum’s Orlynvah for Uncomplicated UTIs, Offering New Hope for Patients with Limited Treatment Options

6 months ago talkbio0Tagged Approved, Iterum, Microbicides, oral antibiotic, Orlynvah, Resistance (Psychotherapeutic), United States Food and Drug Administration, Urinary tract infection, uUTIs

Iterum Therapeutics, Orlynvah, FDA approval, uncomplicated urinary tract infections (uUTIs), oral antibiotic, sulopenem, antimicrobial resistance

FDA Advisors Seek Narrower Indication for Iterum’s Oral Sulopenem in Treating Uncomplicated Urinary Tract Infections

8 months ago talkbio0Tagged AMDAC, Iterum, Microbicides, oral sulopenem, Resistance (Psychotherapeutic), United States Food and Drug Administration, Urinary tract infection, uUTIs

FDA, Iterum Therapeutics, oral sulopenem, uncomplicated urinary tract infections (uUTIs), antimicrobial resistance, Antimicrobial Drugs Advisory Committee (AMDAC)

Lilly Collaborates with OpenAI to Develop Novel Antibiotics Against Drug-Resistant Pathogens

10 months ago talkbio0Tagged Antibiotics, Drug Industry, drug-resistant, Eli Lilly, Generative AI, Microbicides, OpenAI, pathogens, Resistance (Psychotherapeutic)

Lilly, OpenAI, Antibiotics, Antimicrobial Resistance, Drug-Resistant Pathogens, Generative AI, Pharmaceutical Industry

Novo, Gates, and Wellcome Join Forces with $300 Million Initiative to Tackle Global Infectious Diseases

12 months ago talkbio0Tagged Collaboration, Communicable Diseases, development aspects, Global Health, Holdings, Melinda, Microbicides, pandemic preparedness, research, Resistance (Psychotherapeutic), Trust (Social Behavior), Wellcome

Novo Holdings, Bill & Melinda Gates Foundation, Wellcome Trust, infectious diseases, global health, pandemic preparedness, antimicrobial resistance, research and development, funding, collaboration.